JPS6254304B2 - - Google Patents
Info
- Publication number
- JPS6254304B2 JPS6254304B2 JP54125565A JP12556579A JPS6254304B2 JP S6254304 B2 JPS6254304 B2 JP S6254304B2 JP 54125565 A JP54125565 A JP 54125565A JP 12556579 A JP12556579 A JP 12556579A JP S6254304 B2 JPS6254304 B2 JP S6254304B2
- Authority
- JP
- Japan
- Prior art keywords
- yloxy
- propyl
- oxo
- iodide
- tetrahydroquinolin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 13
- 125000005843 halogen group Chemical group 0.000 claims description 13
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical group C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 claims description 11
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- 125000003884 phenylalkyl group Chemical group 0.000 claims description 6
- 125000001424 substituent group Chemical group 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 5
- 125000000304 alkynyl group Chemical group 0.000 claims description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 125000002947 alkylene group Chemical group 0.000 claims description 3
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 claims description 2
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 2
- -1 4-phenylbutyl Chemical group 0.000 description 99
- 150000001875 compounds Chemical class 0.000 description 77
- 238000006243 chemical reaction Methods 0.000 description 49
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 45
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 27
- 238000002844 melting Methods 0.000 description 25
- 230000008018 melting Effects 0.000 description 25
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 25
- 239000013078 crystal Substances 0.000 description 24
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 23
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 20
- 239000000243 solution Substances 0.000 description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 17
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 17
- 239000002904 solvent Substances 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 150000007514 bases Chemical class 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
- 239000002994 raw material Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 150000001298 alcohols Chemical class 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 235000011121 sodium hydroxide Nutrition 0.000 description 7
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 150000002170 ethers Chemical class 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 5
- 238000010992 reflux Methods 0.000 description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 description 5
- 235000017550 sodium carbonate Nutrition 0.000 description 5
- 239000012312 sodium hydride Substances 0.000 description 5
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 4
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229910052801 chlorine Inorganic materials 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000002140 halogenating effect Effects 0.000 description 4
- 229960001340 histamine Drugs 0.000 description 4
- 239000012442 inert solvent Substances 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 229910052700 potassium Inorganic materials 0.000 description 4
- 239000011591 potassium Substances 0.000 description 4
- 229960003975 potassium Drugs 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 3
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 230000001387 anti-histamine Effects 0.000 description 3
- 239000000739 antihistaminic agent Substances 0.000 description 3
- 239000003874 central nervous system depressant Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- YKWNUSJLICDQEO-UHFFFAOYSA-N ethoxyethane;propan-2-ol Chemical compound CC(C)O.CCOCC YKWNUSJLICDQEO-UHFFFAOYSA-N 0.000 description 3
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- HHAVHBDPWSUKHZ-UHFFFAOYSA-N propan-2-ol;propan-2-one Chemical compound CC(C)O.CC(C)=O HHAVHBDPWSUKHZ-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 150000003512 tertiary amines Chemical class 0.000 description 3
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 229910021607 Silver chloride Inorganic materials 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 229910001516 alkali metal iodide Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical group 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000006704 dehydrohalogenation reaction Methods 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 150000004820 halides Chemical class 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical group C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 2
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 235000009518 sodium iodide Nutrition 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- BLIQUJLAJXRXSG-UHFFFAOYSA-N 1-benzyl-3-(trifluoromethyl)pyrrolidin-1-ium-3-carboxylate Chemical compound C1C(C(=O)O)(C(F)(F)F)CCN1CC1=CC=CC=C1 BLIQUJLAJXRXSG-UHFFFAOYSA-N 0.000 description 1
- OBKHBAUDXXJBNK-UHFFFAOYSA-M 1-benzyl-5-[2-hydroxy-3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydroquinolin-2-one;iodide Chemical compound [I-].C1CC(C=2C=CC=CC=2)CC[N+]1(C)CC(O)COC(C=1CCC2=O)=CC=CC=1N2CC1=CC=CC=C1 OBKHBAUDXXJBNK-UHFFFAOYSA-M 0.000 description 1
- AFWCZKJVSFJVRU-UHFFFAOYSA-M 1-methyl-7-[3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydroquinolin-2-one;iodide Chemical compound [I-].C1=C2N(C)C(=O)CCC2=CC=C1OCCC[N+](CC1)(C)CCC1C1=CC=CC=C1 AFWCZKJVSFJVRU-UHFFFAOYSA-M 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- LLSKXGRDUPMXLC-UHFFFAOYSA-N 1-phenylpiperidine Chemical compound C1CCCCN1C1=CC=CC=C1 LLSKXGRDUPMXLC-UHFFFAOYSA-N 0.000 description 1
- ZFFBIQMNKOJDJE-UHFFFAOYSA-N 2-bromo-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(Br)C(=O)C1=CC=CC=C1 ZFFBIQMNKOJDJE-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000000069 2-butynyl group Chemical group [H]C([H])([H])C#CC([H])([H])* 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- TZOYXRMEFDYWDQ-UHFFFAOYSA-N 3,4-dihydro-1h-quinolin-2-one Chemical compound C1=CC=C2NC(=O)CCC2=C1 TZOYXRMEFDYWDQ-UHFFFAOYSA-N 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- UTBULQCHEUWJNV-UHFFFAOYSA-N 4-phenylpiperidine Chemical compound C1CNCCC1C1=CC=CC=C1 UTBULQCHEUWJNV-UHFFFAOYSA-N 0.000 description 1
- MZKLZEDHPGATAW-UHFFFAOYSA-N 5-[2-hydroxy-3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;iodide Chemical compound [I-].C1C[N+](C)(CC(O)COC=2C=3CCC(=O)NC=3C=CC=2)CCC1C1=CC=CC=C1 MZKLZEDHPGATAW-UHFFFAOYSA-N 0.000 description 1
- ULQHEOIVTFNSRO-UHFFFAOYSA-N 5-[2-hydroxy-3-[4-(4-methoxyphenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-1h-quinolin-2-one;iodide Chemical compound [I-].C1=CC(OC)=CC=C1C1CC[N+](C)(CC(O)COC=2C=3C=CC(=O)NC=3C=CC=2)CC1 ULQHEOIVTFNSRO-UHFFFAOYSA-N 0.000 description 1
- WCOZLYZUJRZTES-UHFFFAOYSA-M 5-[3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-1-prop-2-ynyl-3,4-dihydroquinolin-2-one;chloride Chemical compound [Cl-].C1C[N+](C)(CCCOC=2C=3CCC(=O)N(CC#C)C=3C=CC=2)CCC1C1=CC=CC=C1 WCOZLYZUJRZTES-UHFFFAOYSA-M 0.000 description 1
- OOVNUBYNHCYAQU-UHFFFAOYSA-N 5-[3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1H-quinolin-2-one iodide Chemical compound [I-].C1C[N+](C)(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1C1=CC=CC=C1 OOVNUBYNHCYAQU-UHFFFAOYSA-N 0.000 description 1
- RRHSNCOODZVVID-UHFFFAOYSA-N 5-[3-(4-benzyl-1-methylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1H-quinolin-2-one iodide Chemical compound [I-].C1C[N+](C)(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1CC1=CC=CC=C1 RRHSNCOODZVVID-UHFFFAOYSA-N 0.000 description 1
- SCTZVLSKHCDAGH-UHFFFAOYSA-N 5-[3-[1-methyl-4-(2-methylphenyl)piperidin-1-ium-1-yl]propoxy]-3,4-dihydro-1h-quinolin-2-one;iodide Chemical compound [I-].CC1=CC=CC=C1C1CC[N+](C)(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CC1 SCTZVLSKHCDAGH-UHFFFAOYSA-N 0.000 description 1
- HOMYYJWAGUBEQZ-UHFFFAOYSA-N 5-[3-[1-methyl-4-(3-methylphenyl)piperidin-1-ium-1-yl]propoxy]-1h-quinolin-2-one;iodide Chemical compound [I-].CC1=CC=CC(C2CC[N+](C)(CCCOC=3C=4C=CC(=O)NC=4C=CC=3)CC2)=C1 HOMYYJWAGUBEQZ-UHFFFAOYSA-N 0.000 description 1
- DMCZAIREOKZGNK-UHFFFAOYSA-N 5-[3-[4-(2-fluorophenyl)-1-methylpiperidin-1-ium-1-yl]-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one;iodide Chemical compound [I-].C1C[N+](C)(CC(O)COC=2C=3CCC(=O)NC=3C=CC=2)CCC1C1=CC=CC=C1F DMCZAIREOKZGNK-UHFFFAOYSA-N 0.000 description 1
- IWUUYNCFXGGDGT-UHFFFAOYSA-N 5-[3-[4-(2-fluorophenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].C1C[N+](C)(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CCC1C1=CC=CC=C1F IWUUYNCFXGGDGT-UHFFFAOYSA-N 0.000 description 1
- VSLYZYISFIFOBW-UHFFFAOYSA-N 5-[3-[4-(4-methoxyphenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].C1=CC(OC)=CC=C1C1CC[N+](C)(CCCOC=2C=3CCC(=O)NC=3C=CC=2)CC1 VSLYZYISFIFOBW-UHFFFAOYSA-N 0.000 description 1
- DMALAVLWXBPTHN-UHFFFAOYSA-N 6-chloro-7-[2-hydroxy-3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;iodide Chemical compound [I-].C1C[N+](C)(CC(O)COC=2C(=CC=3CCC(=O)NC=3C=2)Cl)CCC1C1=CC=CC=C1 DMALAVLWXBPTHN-UHFFFAOYSA-N 0.000 description 1
- BIAXSLJAEZKTDF-UHFFFAOYSA-N 6-chloro-7-[3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].C1C[N+](C)(CCCOC=2C(=CC=3CCC(=O)NC=3C=2)Cl)CCC1C1=CC=CC=C1 BIAXSLJAEZKTDF-UHFFFAOYSA-N 0.000 description 1
- ABZPKXDVDPOCMW-UHFFFAOYSA-N 7-[2-hydroxy-3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].C1C[N+](C)(CC(O)COC=2C=C3NC(=O)CCC3=CC=2)CCC1C1=CC=CC=C1 ABZPKXDVDPOCMW-UHFFFAOYSA-N 0.000 description 1
- ZYWSWNOBWKJCOW-UHFFFAOYSA-N 7-[2-hydroxy-3-[1-methyl-4-(2-methylphenyl)piperidin-1-ium-1-yl]propoxy]-1h-quinolin-2-one;iodide Chemical compound [I-].CC1=CC=CC=C1C1CC[N+](C)(CC(O)COC=2C=C3NC(=O)C=CC3=CC=2)CC1 ZYWSWNOBWKJCOW-UHFFFAOYSA-N 0.000 description 1
- UFVQHCXQIBJQBE-UHFFFAOYSA-N 7-[2-hydroxy-3-[4-(2-methoxyphenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].COC1=CC=CC=C1C1CC[N+](C)(CC(O)COC=2C=C3NC(=O)CCC3=CC=2)CC1 UFVQHCXQIBJQBE-UHFFFAOYSA-N 0.000 description 1
- QDXHSQRGQKZRHJ-UHFFFAOYSA-N 7-[3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-1H-quinolin-2-one iodide Chemical compound [I-].C1C[N+](C)(CCCOC=2C=C3NC(=O)C=CC3=CC=2)CCC1C1=CC=CC=C1 QDXHSQRGQKZRHJ-UHFFFAOYSA-N 0.000 description 1
- QAYXBRWFCFICBW-UHFFFAOYSA-N 7-[3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].C1C[N+](C)(CCCOC=2C=C3NC(=O)CCC3=CC=2)CCC1C1=CC=CC=C1 QAYXBRWFCFICBW-UHFFFAOYSA-N 0.000 description 1
- LRBSDJLVRUDSMP-UHFFFAOYSA-N 7-[3-(1-methyl-4-phenylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;iodide Chemical compound [I-].C1C[N+](C)(CCCOC=2C=C3NC(=O)CCC3=CC=2)CCC1C1=CC=CC=C1 LRBSDJLVRUDSMP-UHFFFAOYSA-N 0.000 description 1
- XPNCTTMZNXESCK-UHFFFAOYSA-N 7-[3-(4-benzyl-1-methylpiperidin-1-ium-1-yl)propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].C1C[N+](C)(CCCOC=2C=C3NC(=O)CCC3=CC=2)CCC1CC1=CC=CC=C1 XPNCTTMZNXESCK-UHFFFAOYSA-N 0.000 description 1
- CKNWMZSCCMVQBB-UHFFFAOYSA-N 7-[3-[1-methyl-4-(3,4,5-trimethoxyphenyl)piperidin-1-ium-1-yl]propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].COC1=C(OC)C(OC)=CC(C2CC[N+](C)(CCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1 CKNWMZSCCMVQBB-UHFFFAOYSA-N 0.000 description 1
- MGRSOCHRISKEOB-UHFFFAOYSA-N 7-[3-[4-(2,3-dimethylphenyl)-1-methylpiperidin-1-ium-1-yl]-2-hydroxypropoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].CC1=CC=CC(C2CC[N+](C)(CC(O)COC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1C MGRSOCHRISKEOB-UHFFFAOYSA-N 0.000 description 1
- LMVZOEPGKXFKTD-UHFFFAOYSA-N 7-[3-[4-(2,3-dimethylphenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-3,4-dihydro-1h-quinolin-2-one;chloride Chemical compound [Cl-].CC1=CC=CC(C2CC[N+](C)(CCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1C LMVZOEPGKXFKTD-UHFFFAOYSA-N 0.000 description 1
- ZNDDOWFEPJCBPV-UHFFFAOYSA-N 7-[3-[4-(2-methoxyphenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-3,4-dihydro-1h-quinolin-2-one;iodide Chemical compound [I-].COC1=CC=CC=C1C1CC[N+](C)(CCCOC=2C=C3NC(=O)CCC3=CC=2)CC1 ZNDDOWFEPJCBPV-UHFFFAOYSA-N 0.000 description 1
- FVRHRGAMGFNRBD-UHFFFAOYSA-N 7-[3-[4-(3-chlorophenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-3,4-dihydro-1h-quinolin-2-one;iodide Chemical compound [I-].C1C[N+](C)(CCCOC=2C=C3NC(=O)CCC3=CC=2)CCC1C1=CC=CC(Cl)=C1 FVRHRGAMGFNRBD-UHFFFAOYSA-N 0.000 description 1
- BKNACQIPRZLUDY-UHFFFAOYSA-N 7-[3-[4-(3-methoxyphenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-1h-quinolin-2-one;chloride Chemical compound [Cl-].COC1=CC=CC(C2CC[N+](C)(CCCOC=3C=C4NC(=O)C=CC4=CC=3)CC2)=C1 BKNACQIPRZLUDY-UHFFFAOYSA-N 0.000 description 1
- IZLKEOYSQAJSOI-UHFFFAOYSA-N 7-[3-[4-(4-fluorophenyl)-1-methylpiperidin-1-ium-1-yl]propoxy]-1h-quinolin-2-one;iodide Chemical compound [I-].C1C[N+](C)(CCCOC=2C=C3NC(=O)C=CC3=CC=2)CCC1C1=CC=C(F)C=C1 IZLKEOYSQAJSOI-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ZKQDCIXGCQPQNV-UHFFFAOYSA-N Calcium hypochlorite Chemical compound [Ca+2].Cl[O-].Cl[O-] ZKQDCIXGCQPQNV-UHFFFAOYSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- MFESCIUQSIBMSM-UHFFFAOYSA-N I-BCP Chemical compound ClCCCBr MFESCIUQSIBMSM-UHFFFAOYSA-N 0.000 description 1
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 208000012545 Psychophysiologic disease Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002932 anti-schizophrenic effect Effects 0.000 description 1
- 239000000228 antimanic agent Substances 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 1
- 229910001863 barium hydroxide Inorganic materials 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000021703 chronic tic disease Diseases 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000010931 ester hydrolysis Methods 0.000 description 1
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 description 1
- ZYBWTEQKHIADDQ-UHFFFAOYSA-N ethanol;methanol Chemical compound OC.CCO ZYBWTEQKHIADDQ-UHFFFAOYSA-N 0.000 description 1
- MDKXBBPLEGPIRI-UHFFFAOYSA-N ethoxyethane;methanol Chemical compound OC.CCOCC MDKXBBPLEGPIRI-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- CUILPNURFADTPE-UHFFFAOYSA-N hypobromous acid Chemical compound BrO CUILPNURFADTPE-UHFFFAOYSA-N 0.000 description 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 208000010753 nasal discharge Diseases 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- RPDAUEIUDPHABB-UHFFFAOYSA-N potassium ethoxide Chemical compound [K+].CC[O-] RPDAUEIUDPHABB-UHFFFAOYSA-N 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 238000012746 preparative thin layer chromatography Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 125000004213 tert-butoxy group Chemical group [H]C([H])([H])C(O*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12556579A JPS5649360A (en) | 1979-09-28 | 1979-09-28 | 2-oxoquinoline derivative |
DE19803034237 DE3034237A1 (de) | 1979-09-18 | 1980-09-11 | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel |
FR8019708A FR2465732A1 (fr) | 1979-09-18 | 1980-09-12 | Nouveaux derives de carbostyrile, leur procede de preparation et leur application en therapeutique |
AU62381/80A AU518144B2 (en) | 1979-09-18 | 1980-09-12 | Process |
SU802982853A SU1091857A3 (ru) | 1979-09-18 | 1980-09-16 | Способ получени производных карбостирила или их фармакологически приемлемых кислотно-аддитивных или четвертичных солей |
FI802905A FI76322C (fi) | 1979-09-18 | 1980-09-16 | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara karbostyrilderivat. |
CA000360402A CA1151172A (en) | 1979-09-18 | 1980-09-17 | 3-piperidinopropoxy carbostyril derivatives |
NLAANVRAGE8005188,A NL187912C (nl) | 1979-09-18 | 1980-09-17 | Farmaceutisch preparaat dat een carbostyrilderivaat bevat, alsmede carbostyrilderivaat, gesubstitueerd door een (1-piperidyl)alkoxygroep. |
PT71810A PT71810B (en) | 1979-09-18 | 1980-09-17 | Carbostyril derivatives process for producing thereof and antihistaminic agents containing the same |
SE8006498A SE439632B (sv) | 1979-09-18 | 1980-09-17 | Karbostyrilderivat, forfarande for framstellning av den och antihistaminmedel |
CH694080A CH645892A5 (de) | 1979-09-18 | 1980-09-17 | Carbostyrilderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende, antihistaminisch wirkende mittel. |
DK394080A DK158984C (da) | 1979-09-18 | 1980-09-17 | Analogifremgangsmaade til fremstilling af carbostyrilderivater |
AR282565A AR230280A1 (es) | 1979-09-18 | 1980-09-17 | Procedimiento para obtener derivados de carboestirilo y sus sales |
AT0465780A AT376972B (de) | 1979-09-18 | 1980-09-17 | Verfahren zum herstellen neuer carbostyrilderivate und von saeureadditionssalzen und quaternaeren salzen hievon und ihren optischen isomeren |
NO802762A NO154841C (no) | 1979-09-18 | 1980-09-17 | Analogifremgangsmaate for fremstilling av farmakologisk aktive karbo styrilderivater. |
IT68445/80A IT1129263B (it) | 1979-09-18 | 1980-09-18 | Derivati carbostirilici procedimento per la loro preparazione e prodotti antiistaminici contenenti tali derivati |
MX809034U MX6806E (es) | 1979-09-18 | 1980-09-18 | Procedimiento para producir derivados de carboestirilo |
ES495163A ES8200679A1 (es) | 1979-09-18 | 1980-09-18 | Un procedimiento para la preparacion de derivados de carboestirilo. |
GB8030207A GB2063869B (en) | 1979-09-18 | 1980-09-18 | Carbostyril derivatives processes for their production and antihistaminic agents containing them |
US06/357,769 US4482560A (en) | 1979-09-18 | 1982-03-12 | Carbostyril derivatives, and antihistaminic agents containing the same |
AR289431A AR230059A1 (es) | 1979-09-18 | 1982-05-18 | Procedimiento para obtener derivados de piperidil-1-il-alcoxi o hidroxialcoxi-carboestirilo o 3,4-dihidrocarboestirilo |
AT68884A AT376973B (de) | 1979-09-18 | 1984-02-29 | Verfahren zum herstellen neuer carbostyrilderivate und von saeureadditionssalzen und quaternaeren salzen hievon und ihren optischen isomeren |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP12556579A JPS5649360A (en) | 1979-09-28 | 1979-09-28 | 2-oxoquinoline derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5649360A JPS5649360A (en) | 1981-05-02 |
JPS6254304B2 true JPS6254304B2 (fi) | 1987-11-13 |
Family
ID=14913332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP12556579A Granted JPS5649360A (en) | 1979-09-18 | 1979-09-28 | 2-oxoquinoline derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5649360A (fi) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007191495A (ja) * | 2001-10-22 | 2007-08-02 | Santen Pharmaceut Co Ltd | 掻痒治療剤 |
-
1979
- 1979-09-28 JP JP12556579A patent/JPS5649360A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5649360A (en) | 1981-05-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1155119A (en) | Carbostyril derivatives, process for producing thereof and pharmaceutical composition containing the same | |
US4734416A (en) | Pharmaceutically useful carbostyril derivatives | |
US4411901A (en) | Benzisothiazole and benzisoxazole piperazine derivatives | |
EP0462813B1 (en) | Bicyclic pyran derivatives and their use as inhibitors of 5-lipoxygenase | |
EP0261688B1 (en) | Imide derivatives, and their production and use | |
US4452799A (en) | Benzisothiazole and benzisoxazole piperazine derivatives | |
US5021420A (en) | Derivatives of (AZA)naphthalenesultam, their preparation and compositions containing them | |
EP0190015B1 (en) | Novel 4h-1-benzopyran-4-ones and their sulphur containing analogs | |
FI76322C (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara karbostyrilderivat. | |
NZ225520A (en) | Benzopyran derivatives and pharmaceutical compositions | |
HU209301B (en) | Process for producing serotonine antagonists and pharmaceutical compositions comprising same | |
JPS6320226B2 (fi) | ||
JPH0212204B2 (fi) | ||
JPS6332069B2 (fi) | ||
JPS628117B2 (fi) | ||
JPS6254304B2 (fi) | ||
JPH0215537B2 (fi) | ||
JPS6331445B2 (fi) | ||
JPS6317071B2 (fi) | ||
US3536715A (en) | 2-lower alkyl-5-(omega-(4-phenyl-1-piperazinyl) lower alkyl)-2h-tetrazoles | |
JPS6346754B2 (fi) | ||
JPS6320233B2 (fi) | ||
JPS628115B2 (fi) | ||
KR840001938B1 (ko) | 카르보스티릴유도체 및 그의 염의 제조방법 | |
KR850001796B1 (ko) | 카르보스티릴 유도체의 제조방법 |